Giulio Cesare Vitali
Papers
1
Total Citations
86
H-Index
1
About
Giulio Cesare Vitali is a leading figure in hepatobiliary and oncologic surgery, whose work has significantly advanced the treatment of early-stage liver cancer. His research centers on comparing and refining therapeutic strategies for hepatocellular carcinoma (HCC), with a particular focus on minimally invasive approaches. Vitali’s most impactful contribution is a landmark 2015 case–control study, cited 86 times, which rigorously compared minimally invasive surgery (MIS) with percutaneous radio frequency ablation (RFA) for single small HCCs (≤3 cm). This work provided crucial evidence that MIS can achieve comparable or superior oncologic outcomes to RFA, helping to shape clinical guidelines and inform surgical decision-making. By systematically evaluating these two modalities, Vitali has helped clarify the optimal management for patients with small, resectable tumors, balancing efficacy with reduced procedural invasiveness. His research is widely recognized for its methodological rigor and direct clinical applicability, making him a respected voice in the ongoing debate over the best first-line treatment for early-stage HCC.
Research Focus
Key Achievements
Top Papers
- 1